{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T15:06:18Z","timestamp":1765638378941,"version":"3.48.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM137953"],"award-info":[{"award-number":["R35GM137953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute Myeloid Leukemia (AML) is a complex and heterogeneous disease identified by severe clinical progression, fast cellular proliferation, and often high mortality rates. Incorporating diverse longitudinal information on patients\u2019 medical histories is essential for developing effective disease predictive models applicable to both research and clinical settings. Here, we present a robust methodology for discovering the regulation of disease progression dynamics from a novel longitudinal, multimodal clinical dataset of patients diagnosed with AML. The medical data were analyzed to reveal the main clinical, genetic, and treatment features modulating disease progression. To discover dynamic mathematical models at the systems level\u2014including the necessary regulatory interactions, parameters, and disease drivers\u2014predictive of AML progression, we developed a\n                    <jats:italic>de novo<\/jats:italic>\n                    inference algorithm based on high-performance evolutionary computation. The results demonstrate that the predictive methodology could accurately estimate the drivers and clinical dynamics of AML progression in terms of blast percentages for both training and novel patients. This approach effectively predicted AML drivers, their mechanistic interactions, and disease progression by leveraging the heterogeneous and longitudinal dynamics of patients\u2019 clinical data. Importantly, this methodology shows significant potential for modeling progression dynamics in other acute diseases, providing a flexible and adaptable framework for advancing clinical and translational research.\n                  <\/jats:p>","DOI":"10.1007\/s10916-025-02317-6","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:42:59Z","timestamp":1765593779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting the Regulatory Dynamics of AML Disease Progression from Longitudinal Multi-Modal Clinical Data"],"prefix":"10.1007","volume":"49","author":[{"given":"Reza","family":"Mousavi","sequence":"first","affiliation":[]},{"given":"Moaath K.","family":"Mustafa Ali","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Lobo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2317_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM (2025) Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management. American Journal of Hematology 100:860\u2013891. https:\/\/doi.org\/10.1002\/ajh.27625","journal-title":"American Journal of Hematology"},{"key":"2317_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2009.11.025","volume":"184","author":"Z Qian","year":"2010","unstructured":"Qian Z, Joslin JohnM, Tennant TR, et al (2010) Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chem Biol Interact 184:50\u201357. https:\/\/doi.org\/10.1016\/j.cbi.2009.11.025","journal-title":"Chem Biol Interact"},{"key":"2317_CR3","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA, Ch\u00e1vez-Valencia V, G\u00f3mez-Guijosa M\u00c1, Cortes-Penagos C (2017) Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis. Int J Hematol Oncol Stem Cell Res 11:328\u2013339","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"2317_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD (2015) Acute Myeloid Leukemia. New England Journal of Medicine 373:1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184","journal-title":"New England Journal of Medicine"},{"key":"2317_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N, et al (2024) Current status and research directions in acute myeloid leukemia. Blood Cancer J 14:1\u201324. https:\/\/doi.org\/10.1038\/s41408-024-01143-2","journal-title":"Blood Cancer J"},{"key":"2317_CR6","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M (2016) Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer Journal 6:e441\u2013e441. https:\/\/doi.org\/10.1038\/bcj.2016.50","journal-title":"Blood Cancer Journal"},{"key":"2317_CR7","doi-asserted-by":"publisher","first-page":"e2300229","DOI":"10.1200\/GO.23.00229","volume":"9","author":"CT Jani","year":"2023","unstructured":"Jani CT, Ahmed A, Singh H, et al (2023) Burden of AML, 1990\u20132019: Estimates From the Global Burden of Disease Study. JCO Glob Oncol 9:e2300229. https:\/\/doi.org\/10.1200\/GO.23.00229","journal-title":"JCO Glob Oncol"},{"key":"2317_CR8","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Ca Cancer J Clin 73:17\u201348","journal-title":"Ca Cancer J Clin"},{"key":"2317_CR9","doi-asserted-by":"publisher","first-page":"103798","DOI":"10.1016\/j.isci.2022.103798","volume":"25","author":"Z Cai","year":"2022","unstructured":"Cai Z, Poulos RC, Liu J, Zhong Q (2022) Machine learning for multi-omics data integration in cancer. iScience 25:103798. https:\/\/doi.org\/10.1016\/j.isci.2022.103798","journal-title":"iScience"},{"key":"2317_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10020-024-01036-x","volume":"31","author":"L Ye","year":"2025","unstructured":"Ye L, Long C, Xu B, et al (2025) Multi\u2013omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study. Mol Med 31:5. https:\/\/doi.org\/10.1186\/s10020-024-01036-x","journal-title":"Mol Med"},{"key":"2317_CR11","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41598-025-85659-y","volume":"15","author":"C Shi","year":"2025","unstructured":"Shi C, Jiang H, Zhao F, et al (2025) Blood metal levels predict digestive tract cancer risk using machine learning in a U.S. cohort. Sci Rep 15:1285. https:\/\/doi.org\/10.1038\/s41598-025-85659-y","journal-title":"Sci Rep"},{"key":"2317_CR12","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1186\/s12885-024-13320-4","volume":"24","author":"R Poursaeed","year":"2024","unstructured":"Poursaeed R, Mohammadzadeh M, Safaei AA (2024) Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review. BMC Cancer 24:1581. https:\/\/doi.org\/10.1186\/s12885-024-13320-4","journal-title":"BMC Cancer"},{"key":"2317_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/bioengineering10020173","volume":"10","author":"F Alharbi","year":"2023","unstructured":"Alharbi F, Vakanski A (2023) Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review. Bioengineering 10:173. https:\/\/doi.org\/10.3390\/bioengineering10020173","journal-title":"Bioengineering"},{"key":"2317_CR14","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","volume":"186","author":"K Swanson","year":"2023","unstructured":"Swanson K, Wu E, Zhang A, et al (2023) From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell 186:1772\u20131791. https:\/\/doi.org\/10.1016\/j.cell.2023.01.035","journal-title":"Cell"},{"key":"2317_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1463962","author":"EL Kurnat-Thoma","year":"2024","unstructured":"Kurnat-Thoma EL, Nogales C, Vasudevan S (2024) Systems and network approaches to precision medicine and healthcare. Front Mol Biosci 11:. https:\/\/doi.org\/10.3389\/fmolb.2024.1463962","journal-title":"Front Mol Biosci"},{"key":"2317_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1402768","author":"Y Lin","year":"2024","unstructured":"Lin Y, Chen Q, Chen T (2024) Recent advancements in machine learning for bone marrow cell morphology analysis. Front Med 11:. https:\/\/doi.org\/10.3389\/fmed.2024.1402768","journal-title":"Front Med"},{"key":"2317_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","volume":"601","author":"S-J Sammut","year":"2022","unstructured":"Sammut S-J, Crispin-Ortuzar M, Chin S-F, et al (2022) Multi-omic machine learning predictor of breast cancer therapy response. Nature 601:623\u2013629. https:\/\/doi.org\/10.1038\/s41586-021-04278-5","journal-title":"Nature"},{"key":"2317_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0140-6736(22)02079-7","volume":"401","author":"IS Forrest","year":"2023","unstructured":"Forrest IS, Petrazzini BO, Duffy \u00c1, et al (2023) Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts. The Lancet 401:215\u2013225. https:\/\/doi.org\/10.1016\/S0140-6736(22)02079-7","journal-title":"The Lancet"},{"key":"2317_CR19","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1182\/bloodadvances.2020002997","volume":"4","author":"J-N Eckardt","year":"2020","unstructured":"Eckardt J-N, Bornh\u00e4user M, Wendt K, Middeke JM (2020) Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects. Blood Advances 4:6077\u20136085. https:\/\/doi.org\/10.1182\/bloodadvances.2020002997","journal-title":"Blood Advances"},{"key":"2317_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/ijlh.13089","volume":"41","author":"HT Salah","year":"2019","unstructured":"Salah HT, Muhsen IN, Salama ME, et al (2019) Machine learning applications in the diagnosis of leukemia: Current trends and future directions. International Journal of Laboratory Hematology 41:717\u2013725. https:\/\/doi.org\/10.1111\/ijlh.13089","journal-title":"International Journal of Laboratory Hematology"},{"key":"2317_CR21","doi-asserted-by":"publisher","first-page":"101192","DOI":"10.1016\/j.beha.2020.101192","volume":"33","author":"N Radakovich","year":"2020","unstructured":"Radakovich N, Cortese M, Nazha A (2020) Acute myeloid leukemia and artificial intelligence, algorithms and new scores. Best Practice & Research Clinical Haematology 33:101192. https:\/\/doi.org\/10.1016\/j.beha.2020.101192","journal-title":"Best Practice & Research Clinical Haematology"},{"key":"2317_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2024.1402926","author":"F Al-Obeidat","year":"2024","unstructured":"Al-Obeidat F, Hafez W, Rashid A, et al (2024) Artificial Intelligence for the detection of Acute Myeloid Leukemia from microscopic blood images; A Systematic Review and Meta-analysis. Front Big Data 7:. https:\/\/doi.org\/10.3389\/fdata.2024.1402926","journal-title":"Front Big Data"},{"key":"2317_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/cas.16374","volume":"116","author":"G Yan","year":"2025","unstructured":"Yan G, Mingyang G, Wei S, et al (2025) Diagnosis and typing of leukemia using a single peripheral blood cell through deep learning. Cancer Science 116:533\u2013543. https:\/\/doi.org\/10.1111\/cas.16374","journal-title":"Cancer Science"},{"key":"2317_CR24","doi-asserted-by":"publisher","unstructured":"Warnat-Herresthal S, Perrakis K, Taschler B, et al (2020) Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics. iScience 23:. https:\/\/doi.org\/10.1016\/j.isci.2019.100780","DOI":"10.1016\/j.isci.2019.100780"},{"key":"2317_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10142-024-01514-9","volume":"25","author":"CI Ajonu","year":"2025","unstructured":"Ajonu CI, Grundy RI, Ball GR, Zafeiris D (2025) Application of a high-throughput swarm-based deep neural network Algorithm reveals SPAG5 downregulation as a potential therapeutic target in adult AML. Funct Integr Genomics 25:8. https:\/\/doi.org\/10.1007\/s10142-024-01514-9","journal-title":"Funct Integr Genomics"},{"key":"2317_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41467-017-02465-5","volume":"9","author":"S-I Lee","year":"2018","unstructured":"Lee S-I, Celik S, Logsdon BA, et al (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42. https:\/\/doi.org\/10.1038\/s41467-017-02465-5","journal-title":"Nat Commun"},{"key":"2317_CR27","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al (2016) Genomic Classification and Prognosis in Acute Myeloid Leukemia. New England Journal of Medicine 374:2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192","journal-title":"New England Journal of Medicine"},{"key":"2317_CR28","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/cancers16223855","volume":"16","author":"F Ally","year":"2024","unstructured":"Ally F, Chen X (2024) Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry. Cancers 16:3855. https:\/\/doi.org\/10.3390\/cancers16223855","journal-title":"Cancers"},{"key":"2317_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-023-00374-z","volume":"7","author":"QT Trac","year":"2023","unstructured":"Trac QT, Pawitan Y, Mou T, et al (2023) Prediction model for drug response of acute myeloid leukemia patients. npj Precis Onc 7:1\u201310. https:\/\/doi.org\/10.1038\/s41698-023-00374-z","journal-title":"npj Precis Onc"},{"key":"2317_CR30","doi-asserted-by":"publisher","first-page":"e30260","DOI":"10.1002\/pbc.30260","volume":"70","author":"L Cao","year":"2023","unstructured":"Cao L, Huang Y-S, Wu C, et al (2023) Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database. Pediatric Blood & Cancer 70:e30260. https:\/\/doi.org\/10.1002\/pbc.30260","journal-title":"Pediatric Blood & Cancer"},{"key":"2317_CR31","doi-asserted-by":"publisher","first-page":"e54740","DOI":"10.2196\/54740","volume":"10","author":"N Islam","year":"2024","unstructured":"Islam N, Reuben JS, Dale J, et al (2024) Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7\u2009+\u20093 Based on Post Treatment Events and Responses: Retrospective Cohort Study. JMIR Cancer 10:e54740. https:\/\/doi.org\/10.2196\/54740","journal-title":"JMIR Cancer"},{"key":"2317_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40324-022-00296-z","volume":"79","author":"S Chuli\u00e1n","year":"2022","unstructured":"Chuli\u00e1n S, Mart\u00ednez-Rubio \u00c1, Rosa M, P\u00e9rez-Garc\u00eda VM (2022) Mathematical models of leukaemia and its treatment: a review. SeMA 79:441\u2013486. https:\/\/doi.org\/10.1007\/s40324-022-00296-z","journal-title":"SeMA"},{"key":"2317_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40778-023-00224-5","volume":"9","author":"RK Pedersen","year":"2023","unstructured":"Pedersen RK, Andersen M, Stiehl T, Ottesen JT (2023) Understanding Hematopoietic Stem Cell Dynamics\u2014Insights from Mathematical Modelling. Curr Stem Cell Rep 9:9\u201316. https:\/\/doi.org\/10.1007\/s40778-023-00224-5","journal-title":"Curr Stem Cell Rep"},{"key":"2317_CR34","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1158\/0008-5472.CAN-20-0283","volume":"80","author":"T Stiehl","year":"2020","unstructured":"Stiehl T, Wang W, Lutz C, Marciniak-Czochra A (2020) Mathematical Modeling Provides Evidence for Niche Competition in Human AML and Serves as a Tool to Improve Risk Stratification. Cancer Research 80:3983\u20133992. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0283","journal-title":"Cancer Research"},{"key":"2317_CR35","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1038\/s41598-018-21115-4","volume":"8","author":"T Stiehl","year":"2018","unstructured":"Stiehl T, Ho AD, Marciniak-Czochra A (2018) Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis. Sci Rep 8:2809. https:\/\/doi.org\/10.1038\/s41598-018-21115-4","journal-title":"Sci Rep"},{"key":"2317_CR36","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1109\/TBME.2014.2313226","volume":"61","author":"E Pefani","year":"2014","unstructured":"Pefani E, Panoskaltsis N, Mantalaris A, et al (2014) Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia. IEEE Transactions on Biomedical Engineering 61:2049\u20132056. https:\/\/doi.org\/10.1109\/TBME.2014.2313226","journal-title":"IEEE Transactions on Biomedical Engineering"},{"key":"2317_CR37","doi-asserted-by":"publisher","first-page":"e1010439","DOI":"10.1371\/journal.pcbi.1010439","volume":"18","author":"M Przedborski","year":"2022","unstructured":"Przedborski M, Sharon D, Cathelin S, et al (2022) An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia. PLOS Computational Biology 18:e1010439. https:\/\/doi.org\/10.1371\/journal.pcbi.1010439","journal-title":"PLOS Computational Biology"},{"key":"2317_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/bmt.2013.138","volume":"49","author":"T Stiehl","year":"2014","unstructured":"Stiehl T, Ho AD, Marciniak-Czochra A (2014) The impact of CD34\u2009+\u2009cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling. Bone Marrow Transplant 49:30\u201337. https:\/\/doi.org\/10.1038\/bmt.2013.138","journal-title":"Bone Marrow Transplant"},{"key":"2317_CR39","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.neo.2022.100817","volume":"32","author":"E Kim","year":"2022","unstructured":"Kim E, Hwang E-J, Lee J, et al (2022) Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia. Neoplasia 32:100817. https:\/\/doi.org\/10.1016\/j.neo.2022.100817","journal-title":"Neoplasia"},{"key":"2317_CR40","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.asoc.2015.09.009","volume":"37","author":"R Mousavi","year":"2015","unstructured":"Mousavi R, Eftekhari M (2015) A new ensemble learning methodology based on hybridization of classifier ensemble selection approaches. Applied Soft Computing 37:652\u2013666. https:\/\/doi.org\/10.1016\/j.asoc.2015.09.009","journal-title":"Applied Soft Computing"},{"key":"2317_CR41","doi-asserted-by":"publisher","first-page":"1550017","DOI":"10.1142\/S0219720015500171","volume":"13","author":"R Mousavi","year":"2015","unstructured":"Mousavi R, Eftekhari M, Haghighi MG (2015) A new approach to human microRNA target prediction using ensemble pruning and rotation forest. Journal of Bioinformatics and Computational Biology 13:1550017. https:\/\/doi.org\/10.1142\/S0219720015500171","journal-title":"Journal of Bioinformatics and Computational Biology"},{"key":"2317_CR42","doi-asserted-by":"publisher","first-page":"bbab104","DOI":"10.1093\/bib\/bbab104","volume":"22","author":"R Mousavi","year":"2021","unstructured":"Mousavi R, Konuru SH, Lobo D (2021) Inference of dynamic spatial GRN models with multi-GPU evolutionary computation. Briefings in Bioinformatics 22:bbab104. https:\/\/doi.org\/10.1093\/bib\/bbab104","journal-title":"Briefings in Bioinformatics"},{"key":"2317_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-0716-1831-8_14","volume-title":"Computational Systems Biology in Medicine and Biotechnology: Methods and Protocols","author":"JM Ko","year":"2022","unstructured":"Ko JM, Mousavi R, Lobo D (2022) Computational Systems Biology of Morphogenesis. In: Cortassa S, Aon MA (eds) Computational Systems Biology in Medicine and Biotechnology: Methods and Protocols. Springer US, New York, NY, pp 343\u2013365"},{"key":"2317_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41540-024-00361-5","volume":"10","author":"R Mousavi","year":"2024","unstructured":"Mousavi R, Lobo D (2024) Automatic design of gene regulatory mechanisms for spatial pattern formation. npj Systems Biology and Applications 10:35. https:\/\/doi.org\/10.1038\/s41540-024-00361-5","journal-title":"npj Systems Biology and Applications"},{"key":"2317_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129:424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","journal-title":"Blood"},{"key":"2317_CR46","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al (2019) The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics 95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"Journal of Biomedical Informatics"},{"key":"2317_CR47","first-page":"1345","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood, The Journal of the American Society of Hematology 140:1345\u20131377","journal-title":"The Journal of the American Society of Hematology"},{"key":"2317_CR48","doi-asserted-by":"publisher","unstructured":"Lewis JFM, Daver NG, Robinson NJ, et al (2025) Prevalence of Fms-Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta\u2010Analysis. Cancer Medicine 14:e71205. https:\/\/doi.org\/10.1002\/cam4.71205","DOI":"10.1002\/cam4.71205"},{"key":"2317_CR49","doi-asserted-by":"crossref","unstructured":"Thiede C, Steudel C, Mohr B, et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis: Presented in part at the 42nd Annual Meeting of the American Society of Hematology, December 1\u20135, 2000, San Francisco, CA (abstract 2334). Blood, The Journal of the American Society of Hematology 99:4326\u20134335","DOI":"10.1182\/blood.V99.12.4326"},{"key":"2317_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"DA Pollyea","year":"2023","unstructured":"Pollyea DA, Altman JK, Assi R, et al (2023) Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 21:503\u2013513","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"2317_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5473197","volume":"2017","author":"SF Chaudry","year":"2017","unstructured":"Chaudry SF, Chevassut TJT (2017) Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis. BioMed Research International 2017:1\u201313. https:\/\/doi.org\/10.1155\/2017\/5473197","journal-title":"BioMed Research International"},{"key":"2317_CR52","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/leu.2014.124","volume":"28","author":"AP Im","year":"2014","unstructured":"Im AP, Sehgal AR, Carroll MP, et al (2014) DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia 28:1774\u20131783. https:\/\/doi.org\/10.1038\/leu.2014.124","journal-title":"Leukemia"},{"key":"2317_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1109\/TEVC.2016.2606577","volume":"21","author":"HL Liu","year":"2017","unstructured":"Liu HL, Chen L, Deb K, Goodman ED (2017) Investigating the effect of imbalance between convergence and diversity in evolutionary multiobjective algorithms. IEEE Transactions on Evolutionary Computation 21:408\u2013425. https:\/\/doi.org\/10.1109\/TEVC.2016.2606577","journal-title":"IEEE Transactions on Evolutionary Computation"}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-025-02317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10916-025-02317-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-025-02317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T15:02:23Z","timestamp":1765638143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10916-025-02317-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1007\/s10916-025-02317-6","relation":{},"ISSN":["1573-689X"],"issn-type":[{"type":"electronic","value":"1573-689X"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"183"}}